Neuroinfection|Neuroimmunology Conference|Neurology Conference|Neuroinfection Conference|Clinical Neuroimmunology Conference|Neurological Disorders Conference|Neuroinfectious disorders Conference|Neurovirology Conference|Dallas|USA|UK|Spain|Germany|Middle east|2017

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Harnessing the understanding and advancement in Neurology and Neuroimmunology Research
- Neuroinfection 2017

About Conference

Allied Academics invites all the participants from all over the world to attend 4th International Conference on Neurology and Neuroimmunology from September 18-20, 2017, Dallas, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

The scientific sessions of Neuroinfection 2017 will focus on the current research going areas including Neurology, Neuroinfectious disorders, Neuroimmune interactions, and its wide therapeutic aspects. Hundreds of millions of people worldwide are affected by neuroimmunological disorders. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, and stroke as well as frontotemporal dementia. It is estimated that there are 47.5 million people worldwide with dementia with more than 7.5 million new cases per year - Alzheimer's disease is the most common cause of dementia. Also because of stroke more than 6 million people die per year, More than 50 million people have epilepsy over worldwide.

Why to attend???

Neurology and Neuroimmunology has been become a major challenge for human survival. WHO has produced a report in collaboration with several nongovernmental organizations which addresses that the important human health aspects of the following neuroimmunological disorders epilepsy, headache disorders, multiple sclerosis, dementia, neuroimmunological disorders associated with malnutrition, pain associated with neuroimmunological disorders, Parkinson’s disease, stroke, Alzheimer and some traumatic brain injuries.

This conference provides a platform with its well systematic scientific program to the audience which includes discussions, general talks, keynote presentation and poster sessions etc. Interact with members from the worldwide focused on learning about Neurology and Neuroimmunology and their advancement; this is an opportunity to approach the participants from the Neuropharmacology community.

Other Reasons:

.   World Class Speakers and Fresh New Talent from across the Globe in Health Industry

·   Packed Schedule: Workshops, Multi-track Conference, Expo area and more...

·   To network with your fellow primary care clinicians.

·   To empower yourself to fill the void created by the national shortage of neurologists

·   To educate yourself on the diagnosis and treatment of neuroinfectious diseases.

·   To enhance your ability to treat the growing number of patients affected by these neuroinfectious diseases. 

Target Audience:

·   Neuroimmunologist

·   Neuroimmunology Researchers

·   Neuroimmunology Professors

·   Research scholar, students, Ph.d scholar

·   Medical Colleges and Hospitals

·   Psychiatrists

·   Neurology community, society and associations

·   Business Entrepreneurs

·   Training Institutes

·   Software developing companies

·   Manufacturing Medical Devices Companies

·   Data Management Companies

·   Pharmaceutical industries and Biotech Company 


 


 

Welcome Message

Meet Inspiring Speakers and Experts at our 1000+ Global Events comprehensive of 300+ Conferences, 500+ Workshops and 200+ Symposiums consistently on Pharma, Medicine, Science and Technology.
It is with great bliss to invite you to the official website of the 4th International Conference on Neurology and Neuroimmunology practice slated in September 18-20, 2017 at Dallas, USA.
Neuroinfection 2017 is amongst the most imperative gatherings of clinical neurologist, physicians, psychologists and neuropsychologists, therapists, social workers, nurses, case managers, legal professionals, advocates and all others working in the field of neurology and neuroimmunology, neurologists & Care Practice, a chance to unite each one of those with an enthusiasm; including clinicians, mind experts, specialists, researchers and provides a special opportunity for a variety of stakeholders to present original research and analysis aimed at providing a full picture of the progress being made towards better diagnosis, treatment and long-term care for neuroimmune disorder survivors.
The Neuroinfection 2017 study majorly in brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscles of a living organism.
A Unique Opportunity for Researcher’s, Advertisers and Sponsors at this International event to share their ideas and improve their communication and Networking.

Sessions

Track 1. Neurology and their enhancements

Cognitive enhancement is perhaps one of the most intriguing and controversial topics in neuroscience today.The concept of neurology enhancement is built on the premise that effects of cognitive and mood enhancing medications on the suspect predict effects on the healthy. Nowadays the main classes of drugs used as glutamate activators (ampakine), but wakefulness-promoting agents (modafinil) and potential cognitive enhancers include psychostimulants , which are methylphenidate (MPH) and amphetamine are also frequently used. In the field of Pharmacology, substances that enhance the components of the memory systems: glutamate (neuronal excitation), dopamine or norepinephrine helps to improve brain functionality in healthy person beyond their baseline functioning. 

Track 2. Neuroinfectious Disorders

Neuroinfectious diseases are diseases of the central and peripheral nervous system. In other words, the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscles. Such neurological infections are brain abscesses, neurosyphilis, neuro-HIV, neurocysticercosis and bacterial, viral, parasitic and fungal causing neurologic syndromes such as, encephalitis, myelitis and meningitis. Neurological symptoms may occur due to the infection itself, or due to an immune response.

Track 3: Neuro-immune interaction

In this, we specially focus on neuro-immune interactions which highlight most on-going interesting research aimed at understanding the mutual relationship between the immune and nervous systems. Although neural-immune interactions can often serve to promote healing and recovery against inflammation can also produce remarkable effects in the CNS. Microglia which are the resident immune cells of nervous system, are responsible for initiating neural responses for neuroprotection.

Track 4: Epigenetics of Neuroimmunolgical Disorder

Epigenetic research in the CNS has the ability to find and target novel pathways that regulate disease severance and progression. The epigenetics terminology is mainly used by neurologists to describe the gene expression regulation for long period. Some modifications have done like linked histone modifications, repositioning of nucleosome and covalent modification with DNA for main processes such as memory related, neuronal development and synaptic plasticity, and. This research has fostered a new understanding of addiction and potential treatments for those suffering from this problem.

Track 5: Neuroimmunological infectious diseases

The term neuro-immune disease refers to a group of diseases characterized by acquired deregulation of both the nervous system and the immune system. These neuroimmunological infectious diseases most often follow an inflammatory response and that may cause lifelong disorder and disability. Encephalitis causes inflammation of the brain. Another diseases related to neuro-immune response are such as meningitis, multiple sclerosis, Human T cell leukemia virus I and II, HIV-associated Opportunistic Infections.

Track 6: Clinical Neuroimmunology

Clinical Neuroimmunology: Strokes, Multiple Sclerosis and many Related Disorders provides as a resource for neurologists and physicians take interested in, and dealing with this branch of neurology. The main approach of this branch is to develop neuroprotective treatment approaches and establishing modest examination procedures such as motion analysis, MRI (magnetic resonance imaging) and OCT (optical coherence tomography). This branch provides an introduction to basic reciprocal relation of neurons and immunology and principles of immunotherapy and also serves as a thorough guide to immune-mediated disorders of the central and peripheral nervous system.

Track 7: Autoimmune Neuropathies

Dysfunctioning of the autonomic nervous system is very common in several neurologic disorders. And central nervous system degenerative disorder may cause Dysautonomia. Autonomic dysfunction is a feature of inherited neuropathies. Chronic acquired autonomic neuropathy may also occur in patients with diabetes or amyloidosis. Guillain-Barre syndrome (GBS) is characterized by local inflammation and demyelination of peripheral nerves.

Track 8: Neuropharmacology

Neuropharmacology  is on the simply study and understanding of the mechanism of known exogenous and endogenous chemical agents on neurobiological processes in the nervous system. In the neuropharmacology field, individuals work to produces novel drugs to cure neurochemical disorders, and they have to be responsible for evaluating the level of efficiency and overall safety. Neuropharmacology study includes specializations in such areas as drug neurotoxicity, nervous system disorders, neurotransmission, and behavioural pharmacology. 

Track 9: Neuroinflammation

Neurodegeneration is a process that occurs in the central nervous system. And the hallmark of neurodegeneration is associating with the loss of neuronal structure and function. Neurodegeneration is observed after viral infection and causes 'neurodegenerative diseases’, generally considered in the elder stage, such as multiple sclerosis, Parkinson's disease and Alzheimer's disease that negatively affect mental and physical functioning. Recent research have identified that the inflammatory process as being closely linked with multiple neurodegenerative pathways, which are associated with memory loss, depression, dementia and stress.

Track 10: Neurovirology

Neuro-virology is the clinical and high-quality basic science studies on the pathogenesis of viral infections and molecular biology of the nervous system. And also contained report on discovery of novel therapeutic strategies using neurotropic viral vectors. Neuro-virology does also consider the non-viral infections that affect the central nervous system. Neuro-virology targeted to the disease-causing viruses the mechanism through which they infect the human brain and nervous system.

Track 11: Blood Brain Barrier

The blood brain barrier (BBB) consists of specific control point called physical barriers, transporters and enzymes which together maintain the extracellular basement membrane of the central nervous system (CNS) with reduced vesicular transport. The ability to cross the blood brain barrier must be considered for drugs administered, but whose target must lies inside the brain. The main constituents of the BBB include extracellular matrix and astrocytes.

Track 12: Antibody mediated disorder

Treatment of antibody mediated autoimmune disorders remains a difficult clinical problem. The combinations of corticosteroids with cytotoxic chemotherapeutic agents, effective, have broad immunosuppressive effects involving phagocytic cells, T and B lymphocyte function. Treatment usually requires the long term use of corticosteroids alone or combined with cytotoxic agents. This lack of specificity, coupled with other systemic effects, may cause considerable toxicity and treatment related morbidity. Patients refractory to standard treatment present an even more complex therapeutic challenge. Therefore, agents that would specifically target B lymphocytes might provide a safer and more effective treatment of the antibody associated autoimmune disorders.

13. Neurorehabilitation & Neural repair

Neurorehabilitation is a process of restoration of memory functionality of people with neurological disorders of the nervous system. This process involves methodologies  aimed at removing impairments and disabilities, and ultimately improving quality of life for persons with neurological disorders.Neurorehabilitation include functional areas mobility,  dailylives, and cognitive and mental and communicative abilities. Neurorehabilitation aimed at functional restoration and damage reorganization in the nervous system, and facilitate compensatory and adaptive strategies to improve functioning. The practice of rehabilitation involves a survey, highly dependent on the interaction of multiple disciplines and treatment agents. 

14. Nanoneuromedicines

The scope of nanoneuromedicine has grown rapidly due to the immediate need for  biomarkers and therapies for CNS disorders, traumatic, neuropharmacology, psychiatric, developmental, autoimmune neuromuscular junction disorders, neuroinfectious disorders. The recent enhancements of health care using nanotechnologies and nanomedicines range from biomarker discovery including neuroimaging to therapeutic applications for , inflammatory, infectious, and degenerative disorders of the nervous system.

Many neuroinfectious disorders remain unresolved clinical issues. In many cases, drug simply cannot cross the blood brain barrier (BBB) into the nervous system. The advancement of nanomedicines can improve the delivery of  active biological molecules for targeted therapy and imaging.


Market Analysis

Allied Academics invites all the participants from all over the world to attend the Conference on 4th International Conference on Neurology and Neuroimmunology during September 18-20, 2017, Dallas, USA
Neuroinfection 2017 welcomes presenters, delegates and exhibitors from all over the world to Philadelphia, USA. We are delighted to invite you all to attend and register for the ? 4th International Conference on Neurology and Neuroimmunology?.We invite you to join us at the Neuroinfection 2017, where you will be sure to have a meaningful experience with scholars from around the world.
This conference includes the renowned Scientists, Neurologists, Doctors, Professors, Public health planners, Physicians, Dietitians, Pharmacists, Students under the research of Neurology and Neuroimmunology and therapies and Industrial delegates and those using bioinformatics tools for studying under the single roof to discuss and for improving the current therapies, and exploring new approaches. This conference will offer a best platform with its well organized scientific program on Neurology and Neuroimmunology to the audience which includes keynote lectures, plenary talks, interactive panel discussions, and poster sessions, workshop, symposium etc.

Importance and Scope:

Neurology and Neuroimmunology are the major field in the medical technology today. Neuroinfection disorders are diseases that are related to the central and peripheral nervous system in the body. The nervous and immune systems are two different field, but details of how these two essential systems are integrated and cooperative functionality at the molecular level are the only now being revealed. Most of the recent research in this field has focused on the role of immune cells and their mediators in the initiation and progression of specific neuroimmunological diseases, such as dementia, multiple sclerosis and Alzheimer's disease. But how does autoimmune T cells get into the brain and how do they contribute to neurological diseases? T cell responds against antigens that are originated from the CNS are considered to trigger many neuroimmunological diseases, including multiple sclerosis, meningitis and encephalomyelitis. Is microglial cell activation in the brain neurodestructive or neuroprotective?  Innate and adaptive immune cells are now known to have healing properties in CNS. Their activity should be regulated, and their recruitment should be well controlled and their role appreciation in maintenance of brain plasticity, aging, and chronic neurodevelopmental and neurodegenerative diseases.  Can serum antibodies affect brain functionality? What are the meaningful contributions of genetic determinants to the different sclerosis susceptibility? These and many other questions have important implications for the treatment of neurological disorders with immunogical consent.

Why Dallas, USA?

The 4th International Conference on Neurology and Neuroimmunology is being held in Dallas, USA. United States provides the world?s largest market for pharmaceuticals and leaders in biopharmaceutical research. The global marketing of drugs used in cure of mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This global market is expected to increase at a compound annual growth rate (CAGR) of 2.3% from the 2013 to 2018 and will reach $77.1 billion by 2018. We are concentrated to finding ways to treat and prevent Alzheimer's disease which is a devastating disease that is estimated to rise to 12 million cases by the year 2030. San Antonio has many pharmaceutical companies such as BioNumerik Pharmaceuticals, Evestra, Genemed synthesis, GenSpera, Genzyme, Ockham Development Group, Radiant Research, SRI International and universities and their combined approach aims to develop streamline drug by selecting and optimizing  drugs or compounds in the discovery process earlier. The pharmaceutical pipeline also has over 5,000 new medicines currently in development around the world with approximately 3,400 compounds currently being studied in the United States.  

Hospitals associated with Neurology and Neuroimmunology
Top Hospitals in USA

·   Mayo Clinic, Rochester, Minnesota

·   Johns Hopkins Hospital, Baltimore, Maryland

.   New York-Presbyterian University Hospital of Columbia and Cornell

.   UCSF Medical Center

.   Cleveland Clinic

.   NYU Langone Medical Center

.   Massachusetts General Hospital, Boston

·   University of California?San Francisco Medical Center

·   Mathodist Hospital, San Antonio

.   UCLA Medical Center

.   University of California?Los Angeles Medical Center

·   New York University Langone Medical Center, New York City

.   Barnes-Jewish Hospital/Washington University

.   Hospitals of the University of Pennsylvania?Penn Presbyterian

.   Mount Sinai Hospital

.   Emory University Hospital

.   St. Joseph's Hospital and Medical Center

.   Houston Methodist Hospital

.   Cedars-Sinai Medical Center

.   Rush University Medical Center

.   Northwestern Memorial Hospital, Chicago

·   Baptist Medical Centre, San Antonio

Universities in USA 

·   Stanford University

·   University of North Carolina?? Chapel Hill

·   University of Minnesota

.   University of Pittsburgh

·   University of Kentucky

·   University of Washington

·   University of Texas

·   University of California

.   Johns Hopkins University

·   University of Maryland

·   Trinity University

·   Texas Southern University

·   University of Houston

.   University of California San Diego

.   Harvard University

.   University of California San Francisco

.   University of Pennsylvania

.   Yale University

.   University of Colorado Denver

Worldwide Major Neurology and Neuroinfection 2017 related Associations

·   Malaysian Society of Neurosciences

.   National Meningitis Association

.   The Czech Neuropsychopharmacological Society

·   European Academy of Neurology

·   Deutsche Gesellschaft Fur Neurologieologie

·   International Brain Research Organization

.   Canadian Association for Neuroscience

·   The Neuropathy Association

·   The Primary Care Neurology Society

·   The Spanish Society of Neurology (SEN)

·   Euro pean Parkinson?s disease Association

·   Malaysian Society of Neurosciences

·   Eurospine, the Spine Society of Europe

·   The Spanish Society of Neurology (SEN)

·   The Czech Neuropsychopharmacological Society

·   Belgian Neurological Society

·   National Neurotrauma Society

·   National Parkinson'S Foundation

·   European Society of Neurosonology And Cerebral Hemodynamics

·   Federation of European Neuroscience Societies

·   Canadian Neurological Sciences Federation

Major Neuroimmunology related Associations in USA

·   National Institute Of Environmental Health Sciences

·   The American Society of Neuroimaging

·   American Board of Psychiatry and Neurology, Inc.

·   American Clinical Neurophysiology Society

·   International Neuropsychological Society

·   Society for Neuroscience

.   American Psychological Association

·   International Parkinson and Movement Disorder Society

·   American Neurological Association

·   Southern Clinical Neurological Society

·   International Parkinson And Movement Disorder Society

·   International Neuroethics Society

.   American Academy of Neurology

Institutes funding for research

1)   Neuroimmunology Program, the National Institute of Mental Health (NIMH)

2)   IMSF ? Institute for Multiple Sclerosis Research in Göttingen

3)   McKnight Endowment Fund for Neuroscience

Neurology and Neuroimmunology related companies

.   Biogen

.   Novartis

.   Teva

.   Janssen

.   Sunovion

.   Pfizer

.   Sanofi

.   Allergen

.   Astrazeneca

.   Pristiq

.   Acorda

.   Otsuka

.   Takeda

.   Valeant

Market Capitalization of Neurology and Neuroimmunology companies in 2014 investors provided $3.3 billion into firms that are developing drugs for neurodegenerative or psychiatric illnesses. Some big drug companies, including Biogen, Johnson & Johnson, Roche and Novartis are finding methods to prompt their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years and treatments for diseases such as Alzheimer?s, Dementia, and Parkinson?s too.
 

 


 

 

 

To Collaborate Scientific Professionals around the World

Conference Date September 18-20, 2017
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Venue
&
Hospitality

Embassy Suites by Hilton - Dallas Park Central

13131 North Central Expressway Dallas, TX 75287


Join The Discussion

Contact Desk

Drop us a mail for program enquiry

Jennifer Aniston

neuroinfection@alliedconference.org

+118888438169

Sponser/Exhibiting/advertising

Jennifer Aniston

neuroinfection@alliedconferences.com

+118888438169

General queries

Jennifer Aniston

neuroinfection@alliedconferences.com

+118888438169

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Mail us at

Drop us a mail for program enquiry
neuroinfection@alliedconference.org
Sponser/Exhibiting/advertising
neuroinfection@alliedconferences.com
General queries
neuroinfection@alliedconferences.com

Authorization Policy


Copyright © 2017-2018 Allied Academies, All Rights Reserved.